Our Team
Introduce the scientific, clinical, and business leaders guiding SWL Therapeutics.
President and Chief Scientific Officer
Dr. Wang is a renal and transplant physiology researcher whose NIH-supported work focuses on blood pressure regulation, renal hemodynamics, kidney injury, and graft dysfunction after transplantation. She brings deep expertise in academic discovery and translational research to SWL Therapeutics.
Chief Executive Officer
Mr. Sun brings a technology and entrepreneurship background to SWL Therapeutics. Before 2020, he worked as a software developer and manager, building experience in product execution, team leadership, and operational problem-solving. In 2020, he founded Sundial Financials LLC and has since developed six years of entrepreneurial experience guiding early-stage business strategy and execution.
Clinical Advisor
Dr. Grigore Smirnov is a board-certified nephrologist and internist who has been licensed to practice medicine in Florida since 2009. He is passionate about clinical research and will help guide SWL Therapeutics in translating scientific discoveries from the laboratory into clinical applications that improve patient care.